Item type |
itemtype_ver1(1) |
公開日 |
2022-05-27 |
タイトル |
|
|
タイトル |
Elective nodal irradiation versus involved field radiotherapy for limited disease small cell lung cancer: a single-institution experience |
|
言語 |
en |
著者 |
Suzuki, Gen
Yamazaki, Hideya
Aibe, Norihiro
Masui, Koji
Shimizu, Daisuke
Kimoto, Takuya
Nagasawa, Shinsuke
Takenaka, Tadashi
Masai, Norihisa
Watanabe, Sho
Seri, Sho
Tamaki, Nagara
Takayama, Koichi
Yamada, Kei
|
アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
権利 |
|
|
言語 |
en |
|
権利情報Resource |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
|
権利情報 |
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International |
キーワード |
|
|
主題Scheme |
Other |
|
主題 |
small cell lung cancer |
キーワード |
|
|
主題Scheme |
Other |
|
主題 |
limited disease |
キーワード |
|
|
主題Scheme |
Other |
|
主題 |
chemoradiotherapy |
キーワード |
|
|
主題Scheme |
Other |
|
主題 |
involved field radiotherapy |
キーワード |
|
|
主題Scheme |
Other |
|
主題 |
elective nodal irradiation |
内容記述 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Elective nodal irradiation (ENI) and involved field radiotherapy (IFRT) are definitive radiotherapeutic approaches used to treat patients with limited-disease small cell lung cancer (LD-SCLC). However, no solid consensus exists on their optimal target volume. The current study aimed to assess the clinical outcomes of patients with LD-SCLC who received definitive ENI or IFRT. A retrospective single-institution study of patients who received definitive radiotherapy between 2008 and 2020 was performed. All patients underwent whole-body positron emission tomography/computed tomography before three-dimensional conformal radiotherapy. Among the 37 patients analyzed, 22 and 15 received ENI and IFRT, respectively. The thoracic radiotherapy dose was mostly either 60 Gy in 30 fractions delivered in 2-Gy fractions once daily or 45 Gy in 30 fractions delivered in 1.5-Gy fractions twice daily. The median follow-up period was 21.4 months. A total of 12 patients (32%) experienced locoregional relapse: 10 within and 2 outside the irradiation fields. One patient in the IFRT group experienced isolated nodal failure. Differences in locoregional relapse-free, progression-free, and overall survival rates between ENI and IFRT were not significant. Overall, IFRT did not promote a significant increase in locoregional recurrence compared to ENI. Our findings suggested the utility of IFRT in standard clinical practice and support its use for patients with LD-SCLC. |
|
言語 |
en |
出版者 |
|
|
出版者 |
Nagoya University Graduate School of Medicine, School of Medicine |
|
言語 |
en |
言語 |
|
|
言語 |
eng |
資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
departmental bulletin paper |
出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
ID登録 |
|
|
ID登録 |
10.18999/nagjms.84.2.327 |
|
ID登録タイプ |
JaLC |
関連情報 |
|
|
関連タイプ |
isVersionOf |
|
|
識別子タイプ |
URI |
|
|
関連識別子 |
https://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/842.html |
収録物識別子 |
|
|
収録物識別子タイプ |
PISSN |
|
収録物識別子 |
0027-7622 |
収録物識別子 |
|
|
収録物識別子タイプ |
EISSN |
|
収録物識別子 |
2186-3326 |
書誌情報 |
en : Nagoya Journal of Medical Science
巻 84,
号 2,
p. 327-338,
発行日 2022-05
|